BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26884861)

  • 1. Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinoma.
    Al-Maghrabi J; Emam E; Gomaa W; Al-Qaydy D; Al-Maghrabi B; Buhmeida A; Abuzenadah A; Al-Qahtani M; Al-Ahwal M
    Int J Clin Exp Pathol; 2015; 8(12):15895-902. PubMed ID: 26884861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of VEGFR1/Flt-1 immunoexpression in colorectal carcinoma.
    Al-Maghrabi J; Gomaa W; Buhmeida A; Qari Y; Al-Qahtani M; Al-Ahwal M
    Tumour Biol; 2014 Sep; 35(9):9045-51. PubMed ID: 24908415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
    Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
    Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
    Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
    Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
    Wang L; Liu Q; Lin D; Lai M
    Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence.
    Al-Maghrabi J; Emam E; Gomaa W; Saggaf M; Buhmeida A; Al-Qahtani M; Al-Ahwal M
    BMC Cancer; 2015 Oct; 15():676. PubMed ID: 26459369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
    Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
    Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of clusterin in colorectal carcinoma in relation to clinicopathological criteria.
    Gomaa W; Al-Ahwal M; Al-Maghrabi H; Buhmeida A; Al-Qahtani M; Al-Maghrabi B; Al-Maghrabi J
    Malays J Pathol; 2017 Dec; 39(3):243-250. PubMed ID: 29279586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
    Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
    World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer.
    Kamai T; Shirataki H; Nakanishi K; Furuya N; Kambara T; Abe H; Oyama T; Yoshida K
    BMC Cancer; 2010 Apr; 10():164. PubMed ID: 20426825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
    Yu MH; Luo Y; Qin SL; Zhong M
    Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of sonic hedgehog immunohistochemical expression in colorectal carcinoma.
    Al Ghamdi D; Gomaa W; Abulaban A; Al-Ahwal M; Buhmeida A; Al-Qahtani M; Al-Maghrabi J
    J Microsc Ultrastruct; 2015; 3(4):169-174. PubMed ID: 30023196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients.
    Bendardaf R; Buhmeida A; Hilska M; Laato M; Syrjänen S; Syrjänen K; Collan Y; Pyrhönen S
    Cancer Invest; 2010 Jan; 28(1):38-43. PubMed ID: 20001295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic correlation between MTA2 expression level and colorectal cancer.
    Ding W; Hu W; Yang H; Ying T; Tian Y
    Int J Clin Exp Pathol; 2015; 8(6):7173-80. PubMed ID: 26261611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Ki67 expression is an independent good prognostic marker in colorectal cancer.
    Melling N; Kowitz CM; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
    J Clin Pathol; 2016 Mar; 69(3):209-14. PubMed ID: 26281861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration.
    Gong W; An Z; Wang Y; Pan X; Fang W; Jiang B; Zhang H
    Int J Cancer; 2009 Aug; 125(3):548-55. PubMed ID: 19415746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma.
    Al-Maghrabi J; Gomaa W; Buhmeida A; Al-Qahtani M; Al-Ahwal M
    Anticancer Res; 2012 Aug; 32(8):3455-61. PubMed ID: 22843930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological aspects of the hepatic response to neoadjuvant therapy.
    Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
    Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.